Multi-center Survey on Off-label Drug Use of Ambroxol Hydrochloride Injection
10.6039/j.issn.1001-0408.2017.29.08
- VernacularTitle:盐酸氨溴索注射剂超说明书用药的多中心调查研究
- Author:
Yingtong ZENG
1
;
Lu LIN
;
Sha LAI
;
Yuguan WEN
;
Wenjing QIAN
;
Luanluan CHEN
;
Dayi JIANG
;
Qingqun CAI
;
Xiang GAO
Author Information
1. 广东省人民医院/广东省医学科学院药学部
- Keywords:
Ambroxol;
Off-label drug use;
Multi-center;
Survey
- From:
China Pharmacy
2017;28(29):4060-4065
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate off-label drug use of Ambroxol hydrochloride injection,and to provide reference for further evidence-based evaluation on rationality and standardized management of off-label drug use. METHODS:All medical orders for inpatients receiving Ambroxol hydrochloride injection were selected from 10 hospitals of Guangdong province during Apr. 2014 to Mar. 2015. Situation of drug use in different categories of departments was summarized,the incidence of off-label administation route and off-label dosage were analyzed;according to drug package inserts,prescription daily dose(PDD)and drug utilization in-dex(DUI)were calculated for each category of department,and the degree of off-label dosage was evaluated. RESULTS:A total of 761 821 person·day who used Ambroxol hydrochloride injection was included. Off-label drug use occurred in each category of departments,and the incidence of off-label drug use was 62.10%. The incidence of off-label administration route was 40.51%, mainly atomization inhalation;the incidence of it was the high-est in gynecology and obstetrics department(92.70%).The in-cidence of off-label dosage was 36.30%,and the incidence of it was the highest in cardiothoracic surgery department (85.36%). Departments whose PDDs were higher than the drug package inserts were cardiothoracic surgery department,ICU,surgical department,cardiovascular medicine department,emer-gency department,department of internal medicine and pediatrics department.CONCLUSIONS:Off-label drug use of Ambroxol hy-drochloride injection is common,and the effectiveness,safety and necessity remain controversial,which need to be proved by multi-center randomized controlled prospective trial.
